OnKure Therapeutics, Inc. OKUR Conversion Of Series C Preferred Stock
Conversion Of Series C Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept okur:ConversionOfSeriesCPreferredStock.
The official record: OnKure Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s conversion of series c preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s conversion of series c preferred stock?
- OnKure Therapeutics, Inc. (OKUR) reported conversion of series c preferred stock of $32.46M in Q4 2024.
- What does conversion of series c preferred stock mean?
- A non-cash financing activity representing the conversion of preferred equity shares into common equity. This transaction typically reflects a simplification of the capital structure or the fulfillment of contractual obligations upon a liquidity event.